Omniblend Innovation, Australia’s food technology innovators, has celebrated the recent launch of its flagship product, a clinically-validated, natural pre-meal drink designed to lessen the burden of managing type 2 diabetes (T2D). The initial goal was to provide evidence based health drinks in the field of blood glucose (sugar) management. It was awarded a substantial Commercialisation Australia grant in 2012 to develop a pre-meal drink for the dietary management of type 2 diabetes.
The drink forms a persistent protein-rich layer on the walls of the gastrointestinal tract that regulates the blood glucose spike after a meal for people with type 2 diabetes and pre-diabetes. It is designed for the dietary management of people with pre-diabetes or with moderately well-controlled Type-2 diabetes.
Made with safe, food-grade ingredients, GlucoControl provides:
- An all-natural food product that makes it easier for those with type 2 diabetes to maintain their recommended diet
- A 35% reduction in post meal Glycemic Index in people with type 2 diabetes or pre-diabetes
- Longer feelings of fullness, with clinical studies showing no weight gain with regular use
Experts involved in clinical trials of GlucoControl say the product’s unique properties enable a number of key benefits:
“What we are seeing…in these [trial] patients is a substantial lowering of their postprandial glucose response.” – Professor Chris Rayner, Gastroenterologist, University of Adelaide
“…this formulation does slow gastric emptying and that slowing of gastric emptying leads to a reduction in postprandial glucose, which is substantial. Their Glycated hemoglobin was improved using this treatment.” – Professor Michael Horowitz, Professor of Medicine and Head Endocrine Unit, University of Adelaide
“What’s indisputable is that if you flatten the glycemic curve, your HBA1C should be lower…” – Professor Peter Clifton, School of Pharmacy and Medical Sciences, University of South Australia
Arie Nudel, Managing Director, Omniblend Innovation says the launch is an exciting opportunity to dramatically improve the way type 2 diabetes is managed in Australia and around the world.
“Diabetes is one of biggest challenges facing Australia’s health system, with one Australian developing it every five minutes. The issue costs more than $14 billion each year and that’s just in Australia. Considering that more than 422 million people have type 2 diabetes globally, any product that makes life easier for those living with type 2 diabetes will have a dramatic impact,” he said.
“GlucoControl will empower those with type 2 diabetes to take greater control by opening up a broader range of food items and making it easier for them to stay on track with their recommended diet,” added Nudel.
A study to determine the efficacy of GlucoControl was undertaken by researchers at Baker IDI Heart and Diabetes Institute in Melbourne, an international pioneer in diabetes epidemiology and treatment
GlucoControl is now available at Chemmart and other independent pharmacies at an RRP of AU$19.99.
GlucoControl is to be taken under the medical supervision of a health care professional. It is designed to be used as part of a recommended diabetes diet.
For more information on this product and diabetes visit: http://www.obinnovation.com.au